Transcription Factor NF-&kgr;B Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|3|3|98-122

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.3, Iss.3, 2010-11, pp. : 98-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturally Occurring NF-&kgr;B Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B in Type 1 Diabetes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 208-217

Bentham Science Publishers

Access to resources Recommend Favorite

Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-&kgr;B) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis

By  

Current Cancer Drug Targets, Vol. 7, Iss. 4, 2007-06 ,pp. : 325-334

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminase-Mediated Activation of Nuclear Transcription Factor-&kgr;B in Cancer Cells: A New Therapeutic Opportunity

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 559-565

Bentham Science Publishers

Access to resources Recommend Favorite